BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the selection of ...

A company developing liquid biopsy technology for the early detection of cancers has new data that it is presenting Saturday at a major cancer conference. Menlo Park, California-based Grail said it ...

A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...

As targeted therapies have grown in importance for treating cancers, the ability to detect genetic mutations that tumors carry has as well. While this often involves performing tissue biopsies, there ...

When it comes to treating cancer, an early diagnosis is key. Researchers at Baylor College of Medicine, Baylor Genetics and Miraca Research Institute are working to develop a minimally invasive test ...

Researchers from Memorial Sloan Kettering Cancer Center (MSKCC) in New York have pioneered a new type of liquid biopsy that might be able to monitor the progression and response to treatment of a type ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...